These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 35384451)
1. Disease activity as a risk factor for venous thromboembolism in rheumatoid arthritis analysed using time-averaged DAS28CRP: a nested case-control study. Yoshimura M; Fujieda Y; Sugawara M; Kono M; Kato M; Yokota I; Amengual O; Ito YM; Atsumi T Rheumatol Int; 2022 Nov; 42(11):1939-1946. PubMed ID: 35384451 [TBL] [Abstract][Full Text] [Related]
2. Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization. Holmqvist ME; Neovius M; Eriksson J; Mantel Ä; Wållberg-Jonsson S; Jacobsson LT; Askling J JAMA; 2012 Oct; 308(13):1350-6. PubMed ID: 23032551 [TBL] [Abstract][Full Text] [Related]
3. Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden. Molander V; Bower H; Frisell T; Askling J Ann Rheum Dis; 2021 Feb; 80(2):169-175. PubMed ID: 33032998 [TBL] [Abstract][Full Text] [Related]
5. Risk of venous thromboembolism in patients with rheumatoid arthritis. Kim SC; Schneeweiss S; Liu J; Solomon DH Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1600-7. PubMed ID: 23666917 [TBL] [Abstract][Full Text] [Related]
6. Incidence of venous thromboembolism in rheumatoid arthritis, results from a "real-life" cohort and an appraisal of available literature. Conforti A; Berardicurti O; Pavlych V; Di Cola I; Cipriani P; Ruscitti P Medicine (Baltimore); 2021 Aug; 100(33):e26953. PubMed ID: 34414960 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis? Ozen G; Pedro S; Schumacher R; Simon T; Michaud K RMD Open; 2021 Jun; 7(2):. PubMed ID: 34193517 [TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism and risk of cancer in patients with rheumatoid arthritis. Pedersen AB; Vandenbroucke J; Horváth-Puhó E; Sørensen HT J Thromb Haemost; 2017 Dec; 15(12):2325-2332. PubMed ID: 28913891 [TBL] [Abstract][Full Text] [Related]
9. The risk and trend of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a general population-based study. Li L; Lu N; Avina-Galindo AM; Zheng Y; Lacaille D; Esdaile JM; Choi HK; Aviña-Zubieta JA Rheumatology (Oxford); 2021 Jan; 60(1):188-195. PubMed ID: 32617563 [TBL] [Abstract][Full Text] [Related]
10. Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis. Molander V; Bower H; Askling J Scand J Rheumatol; 2023 Mar; 52(2):111-117. PubMed ID: 35023437 [TBL] [Abstract][Full Text] [Related]
11. Risk of venous thromboembolism associated with methotrexate versus hydroxychloroquine for rheumatoid arthritis: A propensity score-matched cohort study. He M; Pawar A; Desai RJ; Glynn RJ; Lee H; Weinblatt ME; Solomon DH; Kim SC Semin Arthritis Rheum; 2021 Dec; 51(6):1242-1250. PubMed ID: 34757241 [TBL] [Abstract][Full Text] [Related]
12. Risk of venous thromboembolism associated with Janus kinase inhibitors for rheumatoid arthritis: case presentation and literature review. Mori S; Ogata F; Tsunoda R Clin Rheumatol; 2021 Nov; 40(11):4457-4471. PubMed ID: 34554329 [TBL] [Abstract][Full Text] [Related]
13. Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study. Galloway J; Barrett K; Irving P; Khavandi K; Nijher M; Nicholson R; de Lusignan S; Buch MH RMD Open; 2020 Sep; 6(3):. PubMed ID: 32994362 [TBL] [Abstract][Full Text] [Related]
14. Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort Study. Desai RJ; Pawar A; Weinblatt ME; Kim SC Arthritis Rheumatol; 2019 Jun; 71(6):892-900. PubMed ID: 30552833 [TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism risk is lower in patients with atopic dermatitis than other immune-mediated inflammatory diseases: A retrospective, observational, comparative cohort study using US claims data. Merola JF; Ertmer B; Liang H; Yue X; Ofori S; Krueger W J Am Acad Dermatol; 2024 May; 90(5):935-944. PubMed ID: 38147900 [TBL] [Abstract][Full Text] [Related]
16. Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study. Ogdie A; Kay McGill N; Shin DB; Takeshita J; Jon Love T; Noe MH; Chiesa Fuxench ZC; Choi HK; Mehta NN; Gelfand JM Eur Heart J; 2018 Oct; 39(39):3608-3614. PubMed ID: 28444172 [TBL] [Abstract][Full Text] [Related]
17. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. Johannesdottir SA; Horváth-Puhó E; Dekkers OM; Cannegieter SC; Jørgensen JO; Ehrenstein V; Vandenbroucke JP; Pedersen L; Sørensen HT JAMA Intern Med; 2013 May; 173(9):743-52. PubMed ID: 23546607 [TBL] [Abstract][Full Text] [Related]
18. Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees. Yusuf HR; Hooper WC; Grosse SD; Parker CS; Boulet SL; Ortel TL Thromb Res; 2015 Jan; 135(1):50-7. PubMed ID: 25456001 [TBL] [Abstract][Full Text] [Related]
19. Preoperative Prevalence of and Risk Factors for Venous Thromboembolism in Patients with a Hip Fracture: An Indirect Multidetector CT Venography Study. Shin WC; Woo SH; Lee SJ; Lee JS; Kim C; Suh KT J Bone Joint Surg Am; 2016 Dec; 98(24):2089-2095. PubMed ID: 28002372 [TBL] [Abstract][Full Text] [Related]
20. Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population-based case-control study. Johannesdottir SA; Schmidt M; Horváth-Puhó E; Sørensen HT J Thromb Haemost; 2012 May; 10(5):815-21. PubMed ID: 22353382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]